St. Johns Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50
Closed -$3.7K 222
2023
Q4
$3.7K Hold
50
﹤0.01% 145
2023
Q3
$3.41K Hold
50
﹤0.01% 145
2023
Q2
$4.7K Hold
50
﹤0.01% 145
2023
Q1
$3.39K Hold
50
﹤0.01% 136
2022
Q4
$2.48K Hold
50
﹤0.01% 139
2022
Q3
$2K Hold
50
﹤0.01% 146
2022
Q2
$2K Hold
50
﹤0.01% 149
2022
Q1
$3K Hold
50
﹤0.01% 153
2021
Q4
$4K Hold
50
﹤0.01% 160
2021
Q3
$5K Hold
50
﹤0.01% 137
2021
Q2
$6K Buy
+50
New +$5.97K ﹤0.01% 134

Other funds holding EXAS

St. Johns Investment Management's EXAS Position: Q1 2024 in Review

St. Johns Investment Management sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 50 shares — an estimated $3.7K sold.

St. Johns Investment Management first reported a position in EXAS in Q2 2021 and held it in 11 quarters. The position peaked at $6K in Q2 2021. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • St. Johns Investment Management reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
  • St. Johns Investment Management sold 50 Exact Sciences shares in Q1 2024, an estimated $3.7K.
  • St. Johns Investment Management first reported a position in Exact Sciences in Q2 2021 and held it in 11 quarters.
  • St. Johns Investment Management's Exact Sciences position peaked at $6K in Q2 2021.
  • 627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on St. Johns Investment Management's 13F filing for Q1 2024, filed 15 Apr 2024.